114.12
price down icon0.59%   -0.68
pre-market  시장 영업 전:  115.50   1.38   +1.21%
loading
전일 마감가:
$114.80
열려 있는:
$113.45
하루 거래량:
1.51M
Relative Volume:
1.92
시가총액:
$6.41B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-368.13
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
-3.37%
1개월 성능:
-3.98%
6개월 성능:
-31.60%
1년 성능:
-11.93%
1일 변동 폭
Value
$110.85
$115.65
1주일 범위
Value
$110.85
$125.00
52주 변동 폭
Value
$102.97
$182.52

Repligen Corp Stock (RGEN) Company Profile

Name
명칭
Repligen Corp
Name
전화
(781) 449-9560
Name
주소
41 SEYON STREET, WALTHAM, MA
Name
직원
1,778
Name
트위터
@repligen
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
RGEN's Discussions on Twitter

RGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
RGEN
Repligen Corp
114.12 6.64B 633.51M -8.10M 131.26M -0.31
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
511.00 183.59B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
181.28 51.10B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.66 42.51B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
267.40 36.95B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
218.90 15.88B 2.90B 467.20M 306.90M 6.37

Repligen Corp Stock (RGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-22 재개 Stephens Overweight
2025-06-24 개시 Barclays Overweight
2025-04-29 업그레이드 Wolfe Research Peer Perform → Outperform
2025-03-18 개시 Evercore ISI In-line
2025-02-10 개시 TD Cowen Buy
2024-12-17 개시 Canaccord Genuity Hold
2024-11-14 개시 Wolfe Research Peer Perform
2024-08-28 개시 Wells Fargo Overweight
2024-06-26 업그레이드 Deutsche Bank Hold → Buy
2024-06-18 개시 Guggenheim Neutral
2023-12-04 다운그레이드 The Benchmark Company Buy → Hold
2023-07-20 개시 Wells Fargo Overweight
2023-07-05 재개 JP Morgan Overweight
2023-03-28 개시 The Benchmark Company Buy
2022-12-14 개시 Deutsche Bank Hold
2022-12-07 개시 RBC Capital Mkts Sector Perform
2022-07-20 개시 UBS Buy
2021-10-14 개시 Exane BNP Paribas Outperform
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-08-24 재확인 H.C. Wainwright Buy
2020-06-30 재확인 H.C. Wainwright Buy
2020-05-07 재확인 H.C. Wainwright Buy
2020-03-23 재확인 H.C. Wainwright Buy
2019-11-15 개시 Stifel Buy
2019-11-01 업그레이드 First Analysis Sec Outperform → Strong Buy
2019-10-15 개시 SVB Leerink Outperform
2019-08-28 재확인 First Analysis Sec Outperform
2019-08-23 재개 Stephens Overweight
2019-07-22 업그레이드 H.C. Wainwright Neutral → Buy
2018-12-17 업그레이드 CL King Neutral → Buy
2018-11-12 다운그레이드 CL King Buy → Neutral
2018-09-26 개시 H.C. Wainwright Neutral
2017-12-08 개시 Citigroup Buy
2017-12-05 개시 JP Morgan Overweight
2017-11-13 개시 CL King Buy
2017-10-02 업그레이드 First Analysis Sec Equal-Weight → Overweight
2017-07-21 개시 William Blair Outperform
2017-02-13 업그레이드 Piper Jaffray Neutral → Overweight
모두보기

Repligen Corp 주식(RGEN)의 최신 뉴스

pulisher
Jul 22, 2025

Repligen (RGEN) Receives Overweight Rating with $160 Price Targe - GuruFocus

Jul 22, 2025
pulisher
Jul 21, 2025

Here's Why Repligen (RGEN) is a Strong Growth Stock - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

Repligen FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

What analysts say about Repligen Corporation stockExplosive portfolio gains - printweek.in

Jul 20, 2025
pulisher
Jul 19, 2025

Envestnet Asset Management Inc. Reduces Position in Repligen Corporation (NASDAQ:RGEN) - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Repligen Corp to Release Q2 2025 Financial Results and Host Conference Call on July 29, 2025. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

M&T Bank Corp Reduces Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Repligen to Report Second Quarter 2025 Financial Results - The Globe and Mail

Jul 17, 2025
pulisher
Jul 17, 2025

Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 15, 2025

How KEY.PRK stock performs during market volatilityFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why DOCU stock attracts strong analyst attentionHigh Potential Shares - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Life360 Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Protein Purification and Isolation Market Size to Surpass USD 33.02 Billion by 2034 - BioSpace

Jul 15, 2025
pulisher
Jul 15, 2025

Parnassus Mid Cap Growth Fund Q2 2025 Commentary - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Parnassus Mid Cap Fund Q2 2025 Commentary - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Why Repligen Corporation stock attracts strong analyst attentionInstant Stock Updates - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ScanSource Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes HUTCHMED (China) Limited Depositary Receipt stock price move sharplyFree Join Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Repligen Corporation stock performs during market volatility200 Percent Profit Outlook - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Sphere 3D Corp. stock attracts strong analyst attentionFree Stock Trading Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ROAD stock attracts strong analyst attentionTop Analyst Picks - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Evercore ISI Cuts Repligen (NASDAQ:RGEN) Price Target to $130.00 - Defense World

Jul 11, 2025
pulisher
Jul 07, 2025

Repligen And 2 Other Stocks That May Be Trading Below Estimated Value - Yahoo Finance

Jul 07, 2025
pulisher
Jul 06, 2025

GAMMA Investing LLC Boosts Holdings in Repligen Corporation (NASDAQ:RGEN) - Defense World

Jul 06, 2025
pulisher
Jul 06, 2025

Repligen Corporation (NASDAQ:RGEN) Shares Purchased by KBC Group NV - Defense World

Jul 06, 2025
pulisher
Jul 06, 2025

Fluor Corporation (NYSE:FLR) Shares Sold by Amalgamated Bank - Defense World

Jul 06, 2025
pulisher
Jun 29, 2025

Wall Street Zen Downgrades Repligen (NASDAQ:RGEN) to Hold - Defense World

Jun 29, 2025
pulisher
Jun 26, 2025

Improving Process Reliability in mAb Manufacturing - Genetic Engineering and Biotechnology News

Jun 26, 2025
pulisher
Jun 24, 2025

Barclays Initiates Coverage on Repligen (RGEN) with Positive Out - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Barclays initiates Repligen stock with overweight rating on bioprocessing strength - Investing.com

Jun 24, 2025
pulisher
Jun 16, 2025

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jun 16, 2025
pulisher
Jun 16, 2025

Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey

Jun 13, 2025
pulisher
Jun 11, 2025

Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025 - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance

Jun 02, 2025
pulisher
May 31, 2025

Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus

May 31, 2025
pulisher
May 29, 2025

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World

May 29, 2025
pulisher
May 27, 2025

Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK

May 27, 2025

Repligen Corp (RGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.92
price up icon 0.80%
$194.06
price up icon 2.67%
medical_instruments_supplies BAX
$27.51
price up icon 0.51%
$65.37
price up icon 2.64%
medical_instruments_supplies COO
$73.03
price up icon 2.40%
medical_instruments_supplies WST
$218.90
price up icon 4.20%
자본화:     |  볼륨(24시간):